fda glp-1 warning news november 2025 Drugs: Pulse Survey (U.S.) The New York Times spotlighted

Recent studies show that mental and emotional stress, along with nutrient deficiencies, influence eating disorders like binge eating, bulimia, and anorexia

The Bottom Line Tirzepatide produced greater average weight loss than semaglutide in a direct 72-week obesity trial, but that does not make tirzepatide automatically better or semaglutide automatically safer

placebo (2.4% vs

10.3892/etm.2016.3081 Exp Ther Med

In contrast, Noom states that their dosing starts at 25% or less of the standard 0.25 mg dose and escalates at a personalized rate. While microdosing GLP-1 medications may provide a more personalized experience, there are still questions regarding the safety of this practice as there are currently no published studies on the process, and the microdoses may come from a compounding pharmacy